Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)

HKG:2591 Revenue

Guangzhou Innogen Pharmaceutical Group had revenue of 78.22M CNY in the half year ending June 30, 2026. This brings the company's total for the last twelve months to 153.28M, up 171.55% year-over-year. In the year 2025, Guangzhou Innogen Pharmaceutical Group had annual revenue of 131.51M. That makes Guangzhou Innogen Pharmaceutical Group the 33,104th largest company in the world by revenue and 1,989th in Hong Kong.

• Revenue (ttm): 153.28M CNY
• Revenue Growth: +171.55%
• P/S Ratio: 7.96
• Revenue / Employee: 716.27K CNY
• Employees: 214
• Market Cap: 1.41B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	131.51M	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 3, 2026

Data Sources Report a data error